Full Text View  
  Tabular View  
  Contacts and Locations  
  No Study Results Posted  
  Related Studies  
Effect of Burn Size on Cytomegalovirus Reactivation and Correlates of T Cell Immune Function in Burned Patients
This study is currently recruiting participants.
Verified by The University of North Carolina, Chapel Hill, January 2008
Sponsored by: University of North Carolina
Information provided by: The University of North Carolina, Chapel Hill
ClinicalTrials.gov Identifier: NCT00467532
  Purpose

The purpose of this study is to evaluate the effect of burn injury on the human immune system with a focus on cytomegalovirus (CMV) reactivation and the immunologic correlates of latent viral reactivation.

Subjects will be patients admitted to the North Carolina Jaycee Burn Center with burn injury.

Blood samples will be collected over time and will be evaluated for CMV reactivation and immune cell phenotype.


Condition
Burns
Cytomegalovirus

MedlinePlus related topics: Burns Cytomegalovirus Infections
U.S. FDA Resources
Study Type: Observational
Study Design: Cohort, Prospective
Official Title: A Prospective Longitudinal Study of the Effect of Burn Size on Cytomegalovirus Reactivation and Correlates of T Cell Immune Function in Patients Sustaining Significant Burn Injury

Further study details as provided by The University of North Carolina, Chapel Hill:

Biospecimen Retention:   Samples With DNA

Biospecimen Description:

Blood samples


Estimated Enrollment: 50
Study Start Date: March 2007
Estimated Study Completion Date: December 2009
Detailed Description:

The purpose of this research study is to learn about infections and the immune system in people who suffer from burn injuries. The immune system changes after burn injury and infection is one of the most common complications. Cytomegalovirus (CMV) is a virus that most people are exposed to early in life; once you are exposed it lays inactive in your body forever. When the immune system is suppressed, this virus can reactivate. We would like to measure how this virus makes copies of itself in the blood stream in people with a burn injury and to look at cell markers of the immune system.

This study involves baseline and weekly blood draws for approximately 8 weeks. If blood tests show CMV infection, further monitoring of blood work may be needed after eight weeks.

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

Patients admitted to the North Carolina Jaycee Burn Center within 72 hours of burn injury with at least a 10% Total Body Surface (TBSA)burn and expected length of stay at least two weeks.

Criteria

Inclusion Criteria:

  • Burn injury,
  • Positive CMV IgG level confirmative of previous CMV infection and latency.

Exclusion Criteria:

  • Immunocompromising conditions including HIV/AIDS,
  • End-stage renal disease,
  • End-stage liver disease,
  • Pregnancy,
  • Rheumatologic or collagen-vascular disease requiring chronic use of steroids,
  • Chronic use of immunosuppressive agents,
  • Recent chemotherapy, and
  • History of solid organ or allogeneic stem cell transplant.
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00467532

Contacts
Contact: Mary V Kessler, RN MSN 919-966-3659 mary_kessler@med.unc.edu
Contact: Valorie Buchholz, RN BSN 919-966-8227 valorie_buchholz@med.unc.edu

Locations
United States, North Carolina
North Carolina Jaycee Burn Center, UNC Hospitals Recruiting
Chapel Hill, North Carolina, United States, 27514
Sponsors and Collaborators
University of North Carolina
Investigators
Principal Investigator: Amanda Peppercorn, MD The University of North Carolina, Chapel Hill
  More Information

Responsible Party: Division of Infectious Diseases, University of North Carolina at Chapel Hill ( Amanda Peppercorn MD )
Study ID Numbers: CMV Reactivation in Burns
Study First Received: April 26, 2007
Last Updated: January 24, 2008
ClinicalTrials.gov Identifier: NCT00467532  
Health Authority: United States: Institutional Review Board

Study placed in the following topic categories:
Virus Diseases
Burns
Wounds and Injuries
Disorders of Environmental Origin
Cytomegalovirus Infections
DNA Virus Infections
Cytomegalic inclusion disease
Cytomegalovirus
Herpesviridae Infections

ClinicalTrials.gov processed this record on January 15, 2009